SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Penumbra, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 16, 2021

New York, New York – (Newsfile Corp. – Jan 26, 2021) – The following statement is made by Levi & Korsinsky, LLP:

To: Any person or entity who purchased or otherwise acquired securities of Penumbra, Inc. (“Penumbra”) (NYSE: PEN) between August 3, 2020 and December 15, 2020. You are hereby notified that a class action lawsuit has been commenced in the United States District Court for the Northern District of California. Further information is available from:

Penumbra, Inc. Loss Submission Form

or contact Joseph E. Levi, Esq. either by email at or by phone at (212) 363-7500. There are no costs or obligations for you.

The complaint alleges that throughout the classroom, defendants made materially false and / or misleading statements and / or failed to disclose that: (1) the Jet 7 Xtra Flex had known design flaws that made it unsafe for normal use ; (2) that Penumbra has not adequately addressed the risk of the Jet 7 Xtra Flex causing serious injury or death that has actually occurred; (3) that the Jet 7 Xtra Flex is likely to be recalled due to its safety issues; and (4) as a result, the public statements by Penumbra set forth above have been materially false and misleading at all relevant times.

If you have suffered a loss in Penumbra, you have until March 16, 2021 to request that the court appoint you as the lead plaintiff. Your ability to partake in a recovery does not require you to be the lead plaintiff.

Levi & Korsinsky is a nationally recognized law firm with offices in New York, California, Connecticut and Washington DC. The firm’s attorneys have extensive expertise and experience representing investors in securities disputes and have recovered hundreds of millions of dollars for aggrieved shareholders. Lawyer advertising. Previous results do not guarantee similar results.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th floor
New York, NY 10006
Tel .: (212) 363-7500
Fax: (212) 363-7171

The source version of this press release can be found at

Comments are closed.